FDA approves the use of ADHD patch for teenagers

07/6/2010 | Bloomberg Businessweek

The Food and Drug Administration has approved Shire's Daytrana skin patch to treat patients ages 13 to 17 who have attention-deficit/hyperactivity disorder. The treatment is already available for children ages 6 to 12 with ADHD.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Learning Assessment Specialist at India's Leading K12 Education Enterprise
XSEED Education (India)
Gurgaon (New Delhi Area)
RFP Specialist, Contract Position
ASCD
Alexandria, VA
DIRECTOR OF LANGUAGE DEVELOPMENT
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
DIRECTOR OF HEALTH AND CULTURE
BOULDER VALLEY SCHOOL DISTRICT
Boulder, CO